Cogent Biosciences (COGT) Stock Highlights

9.08 | +0.22%

2024-11-21 03:43:22

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

Statistics

Range Today

8.93 9.3

Volume Today 1.93M

Range 1 Year

3.67 12.61

Volume 1 Year 389.34M

Range 3 Year

3.67 18.07

Volume 3 Year 861.09M

Range 10 Year

1.18 70.64

Volume 10 Year 1.2B

Highlights

Market Capitalization 1.12B (small)

Floating Shares 70.23M

Current Price 9.08

Price To Earnings -4.04

Price To Book 4.31

Earnings Per Share -2.49

Payout Ratio 0%

Performance

Latest +0.22%

1 Month -23.7%

3 Months -8.84%

6 Months +21.39%

1 Year +13.5%

3 Years -7.16%

5 Years +224.29%

10 Years -80.68%

Benchmarks

Market Capitalization

140 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

89 / 368

Free Cashflow

267 / 352

Performance 5 years

64 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.